Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/19/21 EDT
65.95UNCH (UNCH)
Volume
522,458
Close
65.95UNCH (UNCH)
Volume
6,635,649
52 week range
56.56 - 85.67

...

Loading . . .
  • Open66.70
  • Day High67.00
  • Day Low65.59
  • Prev Close66.87
  • 52 Week High85.67
  • 52 Week High Date04/30/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap83.035B
  • Shares Out1.259B
  • 10 Day Average Volume5.97M
  • Dividend2.84
  • Dividend Yield4.31%
  • Beta0.42
  • YTD % Change13.2

KEY STATS

  • Open66.70
  • Day High67.00
  • Day Low65.59
  • Prev Close66.87
  • 52 Week High85.67
  • 52 Week High Date04/30/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20
  • Market Cap83.035B
  • Shares Out1.259B
  • 10 Day Average Volume5.97M
  • Dividend2.84
  • Dividend Yield4.31%
  • Beta0.42
  • YTD % Change13.2

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)1,157.02
  • Fwd P/E (NTM)9.14
  • EBITDA (MRQ)5.56B
  • ROE (MRQ)0.60%
  • Revenue (MRQ)24.689B
  • Gross Margin (MRQ)81.48%
  • Net Margin (MRQ)0.36%
  • Debt To Equity (MRQ)172.52%

EVENTS

  • Earnings Date04/29/2021
  • Ex Div Date03/12/2021
  • Div Amount0.71
  • Split Date-
  • Split Factor-

Latest From Gilead Sciences Inc

Profile

MORE
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy...
Daniel O'Day
Chairman
Andrew Dickinson
Chief Financial Officer
Flavius Martin M.D.
Executive Vice President
Brett Pletcher
Executive Vice President
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
ZTS
Zoetis Inc
168.10UNCHUNCH
AZN
AstraZeneca PLC
51.63UNCHUNCH
GSK
GlaxoSmithKline PLC
37.98UNCHUNCH
AMGN
Amgen Inc
255.97UNCHUNCH
VRTX
Vertex Pharmaceuticals Inc
219.18UNCHUNCH